Click on a filter below to refine your search. Remove a filter to broaden your search.
Mold may increase the risk for flare-ups and hospitalization with chronic obstructive pulmonary disease.
Active treatment lowered SBP, improved 6-minute walk test and improved measures of endothelial function.
Those receiving pulmonologist-directed treatment have less subsequent healthcare utilization for respiratory illness.
An increase was seen in prebronchodilator forced expiratory volume in one second with dupilumab versus placebo at weeks 12 and 52.
The findings were for veterans with chronic obstructive pulmonary disease, heart failure or interstitial lung disease.
Significant improvement also was seen in lung function, quality of life and severity of COPD symptoms.
Less effect among those who lived in poor-quality neighborhoods suggested in exploratory analysis.
The tool has a sensitivity of 48.2% and a specificity of 88.6% for identifying undiagnosed, clinically significant COPD.
One week of extended-release morphine does not significantly reduce the intensity of the worst breathlessness.
No reduction was seen in the number of self-reported exacerbations treated with oral corticosteroids, antibiotics or both.